SNF8 anticorps (N-Term)
Aperçu rapide pour SNF8 anticorps (N-Term) (ABIN927326)
Antigène
Voir toutes SNF8 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Réactivité croisée
- Souris, Rat (Rattus), Grenouille, Boeuf (Vache), Chien, Poulet, Poisson zebré (Brachydanio rerio)
-
Purification
- Purified
-
Immunogène
- EAP30 antibody was raised in rabbit using the N terminal of EAP30 as the immunogen
-
-
-
-
Indications d'application
- Optimal conditions should be determined by the investigator.
-
Commentaires
-
EAP30 Blocking Peptide, (ABIN5613289), is also available for use as a blocking control in assays to test for specificity of this EAP30 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- SNF8 (Vacuolar-sorting Protein SNF8 (SNF8))
-
Autre désignation
- EAP30
-
Sujet
- ELL encodes an RNA polymerase II transcription factor that undergoes frequent translocation in acute myeloid leukemia. In addition to its elongation activity, ELL contains a novel type of RNA polymerase II interaction domain that is capable of repressing polymerase activity in promoter-specific transcription. EAP30 is a subunit of the ELL complex. EAP30 can interact with ELL and derepress ELL's inhibitory activity in vitro.SNF8, VPS25, and VPS36 form ESCRT-II, a complex involved in endocytosis of ubiquitinated membrane proteins. SNF8, VPS25, and VPS36 are also associated in a multiprotein complex with RNA polymerase II elongation factor. Synonyms: Polyclonal EAP30 antibody, Anti-EAP30 antibodyDot3 antibody, EAP30 antibody, VPS22 antibody.
Antigène
-